Brasofensine: NEUS will begin this year Phase II testing

By WIR Staff | Aug 31, 1998 | 7:00 AM GMT

NeuroSearch A/S (CSE:NEUS), Glostrup, Denmark
Product: Brasofensine

Read the full 74 word article

How to gain access

Continue reading with a
two-week free trial.